"La Fundación Valle del Lili, oficialmente constituida el 25 de noviembre de 1982, es una entidad privada sin ánimo de lucro, que presta servicios de salud de alta complejidad en la ciudad de Santiago de Cali. Está acreditada en excelencia en salud y desde el año 2017 es reconocida formalmente como hospital universitario. Actualmente cuenta con cinco sedes ubicadas en diferentes sectores de la ciudad para facilitar el acceso de los usuarios a los servicios de salud de la institución."

During the past decade, Fundacion Valle del Lili conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 20 clinical trials were completed, i.e. on average, 58.8% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 12 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fundacion Valle del Lili" #1 sponsor was "Fundacion Clinica Valle del Lili" with 12 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored, "Pfizer" with 3 trials sponsored and "Shire" with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundacion Valle del Lili" #1 collaborator was "Eisai Inc." with 2 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Actoverco" with 1 trials as a collaborator, "Ankara University" with 1 trials as a collaborator and "Centre for Chronic Disease Control, India" with 1 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Fundacion Valle del Lili" are "Covid19" (4 trials), "Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Arthritis, Rheumatoid" (2 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Fundacion Valle del Lili" in a lesser frequency.

Most popular intervention types in "Fundacion Valle del Lili" are "Drug" (30 trials), "Biological" (8 trials), "Other" (7 trials), "Procedure" (6 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Ocrelizumab" (3 trials), "Etrolizumab" (2 trials), "Lenvatinib" (2 trials) and "Ontamalimab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fundacion Valle del Lili" are 48 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Fundacion Valle del Lili". undefined are not yet recruiting, 8 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 25 completed trials in Fundacion Valle del Lili, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Fundacion Valle del Lili, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".